The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to ...
Several drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical companies that it alleges are ...
Related: FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers The committee already has passed several bipartisan bills targeting "pay-for-delay" agreements, in which ...
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given ...
The Federal Trade Commission (“FTC”) and the Antitrust Division of the Department of Justice (“DOJ”) announced on Thursday, May 23, that they are expanding their search for businesses using “roll up” ...
Outrage from legions of Beyoncé and Taylor Swift fans about hidden concert ticket fees helped spark a national conversation around “junk fees." It has even filtered into the 2024 election cycle.
WASHINGTON, May 29 (Reuters) - A U.S. judge in Seattle on Tuesday rejected Amazon.com's (AMZN.O) , opens new tab request to dismiss a Federal Trade Commission (FTC) lawsuit that accuses the ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
We've also got a look at the "resilient consumer" and new rules for the buy now, pay later industry. In this podcast, Motley Fool analyst Jason Moser and host Mary Long take a look at Target ...
The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to ...